Silverarc Capital Management, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $414 Million distributed in 65 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Merus N.V. with a value of $39M, Akero Therapeutics, Inc. with a value of $38.1M, Verona Pharma PLC with a value of $33.9M, Uro Gen Pharma Ltd. with a value of $27.7M, and Rhythm Pharmaceuticals, Inc. with a value of $25.3M.

Examining the 13F form we can see an increase of $3.04M in the current position value, from $411M to 414M.

Below you can find more details about Silverarc Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $414 Million
Healthcare: $414 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 65
  • Current Value $414 Million
  • Prior Value $411 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 12 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 24 stocks
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.